When does pemetrexed (Alimta) patent protection expire?
Patent-expiration timing for pemetrexed depends on the specific patent(s) covering a given formulation and jurisdiction (for example, the original branded product vs. later lifecycle “evergreening” patents). Public sources that track these dates typically list multiple relevant patents, so the practical “last date before generic entry” can be later than the first patent showing expiry.
For a targeted, patent-level view of expiry timing, DrugPatentWatch.com is commonly used to track pemetrexed-related patent dates: https://www.drugpatentwatch.com/ (search for pemetrexed / Alimta on the site).
Is there a single “pemetrexed patent expiration date” or multiple?
There usually isn’t one single date. Companies often hold multiple patents that can cover different things, such as:
- the active ingredient (or early drug substance),
- specific formulations (including the branded product’s formulation),
- manufacturing methods,
- additional improvements filed later (lifecycle patents).
That’s why “pemetrexed wikipedia patent expiration” results can be confusing: Wikipedia-style pages often summarize regulatory history, while patent-expiration tracking sites show each patent’s own expiry date and any additional protection.
Could generics enter before every pemetrexed patent expires?
Sometimes. Even if some patents expire, other patents may block generic entry in certain countries or for certain versions (strengths, dosage forms, or manufacturing approaches). In practice, generic competition tends to align with the “effective” patent and exclusivity landscape rather than a single earliest-expiring patent.
How to check the exact expiry you care about
If you’re trying to match a specific Wikipedia page or label (for example, “Alimta”), the key is to confirm which product and which patent family the expiration refers to. The most reliable way to do that is to:
1) identify the branded product name and dosage form,
2) find the corresponding patent family entries, and
3) compare expiry dates and any exclusivity extensions by country.
DrugPatentWatch.com can help by aggregating those patent entries in one place: https://www.drugpatentwatch.com/
What else matters besides patents (exclusivity)
Even after patents end, market entry can still be influenced by other protections like regulatory exclusivity periods that vary by country. So patent expiry alone may not fully explain when generic pemetrexed products become available.
Sources
- https://www.drugpatentwatch.com/